CORC

浏览/检索结果: 共24条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
The discovery of a novel series of potential ERR alpha inverse agonists based on p-nitrobenzenesulfonamide template for triple-negative breast cancer in vivo 期刊论文
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2022, 卷号: 37, 期号: 1, 页码: 125-134
作者:  Gao, Zhipei;  Wang, Tianxiao;  Li, Rui;  Du, Yongli;  Lv, Han
收藏  |  浏览/下载:39/0  |  提交时间:2022/01/18
Tislelizumab (BGB-A317) for relapsed/refractory (R/R) classical Hodgkin lymphoma (cHL): Long-term follow-up efficacy and safety results from a phase 2 study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng
收藏  |  浏览/下载:28/0  |  提交时间:2022/01/10
The Increased Expression of Estrogen-Related Receptor alpha Correlates with Wnt5a and Poor Prognosis in Patients with Glioma 期刊论文
MOLECULAR CANCER THERAPEUTICS, 2019, 卷号: 18, 期号: 1
作者:  Zhang, Liudi;  Zhu, Yingfeng;  Cheng, Haixia;  Zhang, Jinsen;  Zhu, Yuqian
收藏  |  浏览/下载:48/0  |  提交时间:2019/12/05
Treatment of relapsed or refractory classical Hodgkin lymphoma with the anti-PD-1, tislelizumab: results of a phase 2, single-arm, multicenter study 期刊论文
2019
作者:  Song Yuqin;  Gao Quanli;  Zhang Huilai;  Fan Lei;  Zhou Jianfeng
收藏  |  浏览/下载:16/0  |  提交时间:2020/01/03
Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study 期刊论文
BLOOD, 2018, 卷号: 132
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng
收藏  |  浏览/下载:11/0  |  提交时间:2019/12/05
Inhibition of PDGF-BB-induced proliferation and migration in VSMCs by proanthocyanidin A2: Involvement of KDR and Jak-2/STAT-3/cPLA(2) signaling pathways 期刊论文
BIOMEDICINE & PHARMACOTHERAPY, 2018, 卷号: 98
作者:  Zhang, Liudi;  Shao, Jie;  Zhou, Yufu;  Chen, Haifei;  Qi, Huijie
收藏  |  浏览/下载:11/0  |  提交时间:2019/12/05
Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study 会议论文
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/05
Effects of FGFR gene polymorphisms on response and toxicity of cyclophosphamide-epirubicin-docetaxel based chemotherapy in breast cancer patients 期刊论文
BMC CANCER, 2018, 卷号: 18
作者:  Chen, Lu;  Qi, Huijie;  Zhang, Liudi;  Li, Haixia;  Shao, Jie
收藏  |  浏览/下载:9/0  |  提交时间:2019/12/05
Downregulation of estrogen-related receptor alpha inhibits human cutaneous squamous cell carcinoma cell proliferation and migration by regulating EMT via fibronectin and STAT3 signaling pathways 期刊论文
EUROPEAN JOURNAL OF PHARMACOLOGY, 2018, 卷号: 825
作者:  Chen, Haifei;  Pan, Jiewen;  Zhang, Liudi;  Chen, Lu;  Qi, Huijie
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/05
Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study 期刊论文
2018, 卷号: 132
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng
收藏  |  浏览/下载:8/0  |  提交时间:2020/01/03


©版权所有 ©2017 CSpace - Powered by CSpace